No missing data were imputed for the outcome data, and any missing baseline data were imputed as the mean of the participants with this measurement 48 (irrespective of treatment)
Front Pharmacol 14:1330098
Summary Keywords IBD, GLP-1, GLP-1 receptor agonists, diabetes, obesity Citation Migliorisi G, Gabbiadini R, Dal Buono A, Ferraris M, Privitera G, Petronio L, Bertoli P, Bezzio C and Armuzzi A (2025) GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
However, like any medication, GLP-1s bring along their set of considerations, with constipation being a topic that deserves attention
46.STOP-BANG score for obstructive sleep apnea
Peptide therapy, stem cell therapy, and PRP therapy offer innovative solutions for treating lupus and enhancing joint health